rxstat › Shortages › Triamcinolone Acetonide

Triamcinolone Acetonide (Aristocort R, Kenalog-40) shortage status

Partial shortage

Source: Health Canada shortage reports · Updated Oct 30, 2026

Also sold as: Aristocort R, Kenalog-40, Triesence, Triaderm

Some Triamcinolone Acetonide products are in shortage in Canada (3 of 11 reported products), while others remain available. Your pharmacy may be able to substitute an unaffected manufacturer. The latest estimate for affected products to return is Jan 31, 2027.

A corticosteroid used to reduce inflammation in conditions such as skin disorders, allergies and joint problems.

Products affected
3 / 11
In shortage since
Apr 16, 2025
Est. full return
Jan 31, 2027
Reports on file
54
Talk to a pharmacist
Pharmacists can substitute an unaffected manufacturer's version, adjust strengths, and in most provinces adapt or renew a prescription on the spot.
Book a pharmacist appointment
Need your prescription switched?
If your product stays unavailable, an online doctor can assess your situation and prescribe an alternative.
See a doctor online

Independent services, not affiliated with rxstat; referral fees may apply. Free options exist depending on your province. In an emergency call 911; free health advice at 811.

Shortage history

2023 2024 2025 2026

Shortage history (red bands = periods in shortage).

Reports by product

The DIN is printed on your prescription label.

Active shortage
KENALOG-40 INJECTION
40MG · SUSPENSION · BRISTOL-MYERS SQUIBB CANADA
DIN 01999869 · since Apr 16, 2025, no end estimate · Disruption of the manufacture of the drug.
Active shortage
KENALOG-10 INJECTION
10MG · SUSPENSION · BRISTOL-MYERS SQUIBB CANADA
DIN 01999761 · since Jun 13, 2025, no end estimate · Disruption of the manufacture of the drug.
Active shortage
TRIAMCINOLONE ACETONIDE INJECTABLE SUSPENSION USP
40MG · SUSPENSION · STERIMAX INC
DIN 01977563 · since ?, est. end Jan 31, 2027 · Demand increase for the drug.
Active shortage
TRIAMCINOLONE ACETONIDE INJECTABLE SUSPENSION USP
40MG · SUSPENSION · STERIMAX INC
DIN 01977563 · since Aug 27, 2025, est. end Jan 31, 2027 · Delay in shipping of the drug.
Anticipated
TRIESENCE
40MG · SUSPENSION · NOVARTIS PHARMACEUTICALS CANADA INC
DIN 02368676 · Shortage of an active ingredient.
Resolved
APO-TRIAMCINOLONE AQ
55MCG · SPRAY, METERED DOSE · APOTEX INC
DIN 02437635 · ended Oct 15, 2026 · Disruption of the manufacture of the drug.
Resolved
TRIAMCINOLONE ACETONIDE INJECTABLE SUSPENSION USP
40MG · SUSPENSION · STERIMAX INC
DIN 01977563 · ended Aug 15, 2025 · Delay in shipping of the drug.
Resolved
APO-TRIAMCINOLONE AQ
55MCG · SPRAY, METERED DOSE · APOTEX INC
DIN 02437635 · ended Apr 24, 2025 · Disruption of the manufacture of the drug.
Resolved
TRIESENCE
40MG · SUSPENSION · NOVARTIS PHARMACEUTICALS CANADA INC
DIN 02368676 · ended Feb 5, 2025 · Disruption of the manufacture of the drug.
Resolved
ARISTOCORT R
0.1% · CREAM · BAUSCH HEALTH, CANADA INC.
DIN 02194058 · ended Dec 1, 2023 · Format rationalization
Resolved
ARISTOCORT R
0.1% · CREAM · BAUSCH HEALTH, CANADA INC.
DIN 02194058 · ended Sep 19, 2023 · delay in production
Resolved
ARISTOCORT R
0.1% · CREAM · BAUSCH HEALTH, CANADA INC.
DIN 02194058 · ended Jul 18, 2023 · Delay in shipping of the drug.

Showing 12 of 54 reports. All reports are on file with Health Canada.

What's happening

Triamcinolone Acetonide is currently affected by 3 active shortage reports filed with Health Canada by BRISTOL-MYERS SQUIBB CANADA, STERIMAX INC.

The reported causes are: disruption of the manufacture of the drug; demand increase for the drug; delay in shipping of the drug. Manufacturers must report shortages, but end-date estimates are their own projections and often move.

If your usual product is affected, a pharmacist is the fastest route to a solution: they can dispense an unaffected manufacturer's equivalent when one exists, and in most provinces can adapt doses or substitute a therapeutic alternative without a new appointment.

Triamcinolone Acetonide is classified under “CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN” (ATC H02AB).

Recent changes

Common questions

What is Triamcinolone Acetonide used for?

A corticosteroid used to reduce inflammation in conditions such as skin disorders, allergies and joint problems.

When will Triamcinolone Acetonide be back in stock in Canada?

The latest manufacturer estimate is Jan 31, 2027. Estimates are self-reported and often slip; this page updates automatically when they change.

Why is Triamcinolone Acetonide in shortage?

See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.

What can my pharmacist do about it?

Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.

Email alerts

Get an email when this drug's status changes. Double opt-in, one-click unsubscribe.

Possible alternatives in the same class (corticosteroids for systemic use, plain)

Drugs in the same therapeutic class, best-supplied first. These are not automatic substitutes: only your pharmacist or prescriber can judge whether a switch makes sense for you.

Betamethasone (Celestone Soluspan) No current shortage Methylprednisolone (Depo-Medrol) No current shortage Prednisone (Winpred) No current shortage Hydrocortisone (Solu-Cortef) Partial shortage 3 of 16 reported products affected Methylprednisolone (Solu-Medrol) Partial shortage 2 of 11 reported products affected · est. return Nov 30, 2026 Dexamethasone Widespread shortage 2 of 6 reported products affected · est. return May 31, 2027

Guides: what to do when your medication is in shortage · how to read shortage reports

Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.